Pancreatic Cancer Research

ResearcherTUM KlinikumActive in the last 2 years

Rüdiger Göß

Matched on ORCID iD 0000-0002-0407-0394; OpenAlex author ID A5109095251. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 3 papers · 2025: 2 papers

Papers 9

  1. Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. First author DOI 10.1016/j.canlet.2025.217894↗
  2. Pancreatic cancer cells infiltrate nerves through TGFbeta1-driven perineural epithelial-to-mesenchymal-like transdifferentiation. Co-author DOI 10.1016/j.neo.2025.101126↗
  3. A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patients. Co-author DOI 10.1007/s00423-024-03570-y↗
  4. Correlation of intratumoral mast cell quantity with psychosocial distress in patients with pancreatic cancer: the PancStress study. First author DOI 10.1038/s41598-024-77010-8↗
  5. Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. Co-author DOI 10.1093/bjsopen/zrad125↗
  6. Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center. Co-author DOI 10.1097/as9.0000000000000302↗
  7. Patterns and Relevance of Langerhans Islet Invasion in Pancreatic Cancer. Co-author DOI 10.3390/cancers13020249↗
  8. A look at the progress of treating pancreatic cancer over the past 20 years. Co-author DOI 10.1080/14737140.2018.1428093↗
  9. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis. Co-author DOI 10.1016/j.suronc.2017.01.007↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. İhsan Ekin Demir · 8 shared papers, 2017–2025 · strength 1.29
  2. Guralp Onur Ceyhan · 8 shared papers, 2017–2025 · strength 1.29
  3. Helmut Friess · 7 shared papers, 2017–2025 · strength 1.17
  4. Okan Safak · 6 shared papers, 2021–2025 · strength 0.99
  5. Ilaria Pergolini · 5 shared papers, 2023–2025 · strength 0.89
  6. Carmen Mota Reyes · 5 shared papers, 2017–2025 · strength 0.82
  7. Stephan Schorn · 4 shared papers, 2017–2024 · strength 0.56
  8. Alexander Novotny · 3 shared papers, 2023–2024 · strength 0.49
  9. Alexander Muckenhuber · 2 shared papers, 2024–2025 · strength 0.42
  10. Marc Eric Martignoni · 2 shared papers, 2023–2024 · strength 0.30
  11. Maximilian Kießler · 2 shared papers, 2023–2024 · strength 0.30
  12. Helmut Frieß · 2 shared papers, 2018–2021 · strength 0.29
  13. Lei Ren · 2 shared papers, 2021–2023 · strength 0.29
  14. Florian Scheufele · 2 shared papers, 2017–2024 · strength 0.25
  15. Kaan Çifcibaşı · 1 shared paper, 2025 · strength 0.24
  16. Theresa Krauss · 1 shared paper, 2025 · strength 0.22
  17. Dieter Saur · 1 shared paper, 2025 · strength 0.22
  18. Mustapha Adham · 1 shared paper, 2024 · strength 0.18
  19. Julie Périnel · 1 shared paper, 2024 · strength 0.18
  20. Alicia Sitte · 1 shared paper, 2024 · strength 0.16
  21. Paulo Leonardo Pfitzinger · 1 shared paper, 2024 · strength 0.16
  22. Mert Erkan · 1 shared paper, 2024 · strength 0.16
  23. Werner Hartwig · 1 shared paper, 2024 · strength 0.14
  24. Tim R. Glowka · 1 shared paper, 2024 · strength 0.14
  25. Tobias Keck · 1 shared paper, 2024 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.